Pulmonary Disease, Chronic Obstructive Clinical Trial
— STEPOfficial title:
Enhancing Physical Activity to Achieve Sustainable Benefits in Extrapulmonary Consequences of COPD
| NCT number | NCT02702791 |
| Other study ID # | s57963 |
| Secondary ID | |
| Status | Completed |
| Phase | N/A |
| First received | |
| Last updated | |
| Start date | October 2015 |
| Est. completion date | October 2019 |
| Verified date | October 2019 |
| Source | KU Leuven |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
This randomized control trial will investigate whether the implementation of a telecoaching
program, initiated during pulmonary rehabilitation, is able to increase and maintain physical
activity and general benefits until six months after rehabilitation discharge.
After three months of pulmonary rehabilitation (3 times a week), patients with COPD will be
randomized to either an intervention group which receives an additional telecoaching program
on top of the pulmonary rehabilitation, or to the usual care group, which only receives
rehabilitation program. Apart from the added telecoaching program to the intervention group,
the rehabilitation program will be identical and last for another three months (2 times a
week). After discharge, both groups will be followed up for six months.
| Status | Completed |
| Enrollment | 73 |
| Est. completion date | October 2019 |
| Est. primary completion date | September 2019 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 40 Years to 80 Years |
| Eligibility |
Inclusion Criteria: - Patients with a primary diagnosis of COPD according to internationally accepted guidelines - Patients that completed three months of the outpatient pulmonary rehabilitation program of Gasthuisberg University Hospital (Leuven, Belgium) - Current or previous smoking exposure of at least 10 pack years - Ability to manage electronic devices (smartphone, step counter) Exclusion Criteria: - Other predominant respiratory diseases than COPD (asthma, pulmonary hypertension) - Orthopedic, neurological and muscular co morbidities that could interfere with normal biomechanical movement patterns and the ability to increase physical activity levels - Patients on the waiting list for lung transplantation |
| Country | Name | City | State |
|---|---|---|---|
| Belgium | University Hospitals Leuven | Leuven | Vlaams Brabant |
| Lead Sponsor | Collaborator |
|---|---|
| KU Leuven | Conselho Nacional de Desenvolvimento Científico e Tecnológico |
Belgium,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Changes in physical activity (number of steps) | At three and six months of pulmonary rehabilitation and three and six months of follow up | ||
| Secondary | Changes in physical activity (time spent in moderate activity) | At three and six months of pulmonary rehabilitation and three and six months of follow up | ||
| Secondary | Changes in pulmonary rehabilitation outcomes (Quadriceps force) | At three and six months of pulmonary rehabilitation and three and six months of follow up | ||
| Secondary | Changes in pulmonary rehabilitation outcomes (Functional exercise capacity) | At three and six months of pulmonary rehabilitation and three and six months of follow up | ||
| Secondary | Changes in pulmonary rehabilitation outcomes (Maximal exercise capacity) | At three and six months of pulmonary rehabilitation and six months of follow up | ||
| Secondary | Changes in pulmonary rehabilitation outcomes (Endurance exercise capactity) | At three and six months of pulmonary rehabilitation and six months of follow up | ||
| Secondary | Changes in pulmonary rehabilitation outcomes (Quality of life) | At three and six months of pulmonary rehabilitation and six months of follow up |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05043428 -
The Roles of Peers and Functional Tasks in Enhancing Exercise Training for Adults With COPD
|
N/A | |
| Completed |
NCT00528996 -
An Efficacy and Safety Study to Compare Three Doses of BEA 2180 BR to Tiotropium and Placebo in the Respimat Inhaler.
|
Phase 2 | |
| Completed |
NCT03740373 -
A Study to Assess the Pulmonary Distribution of Budesonide, Glycopyrronium and Formoterol Fumarate
|
Phase 1 | |
| Completed |
NCT05402020 -
Effectiveness of Tiotropium + Olodaterol Versus Inhaled Corticosteroids (ICS) + Long-acting β2-agonists (LABA) Among COPD Patients in Taiwan
|
||
| Completed |
NCT05393245 -
Safety of Tiotropium + Olodaterol in Chronic Obstructive Pulmonary Disease (COPD) Patients in Taiwan: a Non-interventional Study Based on the Taiwan National Health Insurance (NHI) Data
|
||
| Completed |
NCT04011735 -
Re-usable Respimat® Soft MistTM Inhaler Study
|
||
| Enrolling by invitation |
NCT03075709 -
The Development, Implementation and Evaluation of Clinical Pathways for Chronic Obstructive Pulmonary Disease (COPD) in Saskatchewan
|
||
| Completed |
NCT03764163 -
Image and Model Based Analysis of Lung Disease
|
Early Phase 1 | |
| Completed |
NCT00515268 -
Endotoxin Challenge Study For Healthy Men and Women
|
Phase 1 | |
| Completed |
NCT04085302 -
TARA Working Prototype Engagement Evaluation: Feasibility Study
|
N/A | |
| Completed |
NCT03691324 -
Training of Inhalation Technique in Hospitalized Chronic Obstructive Pulmonary Disease (COPD) Patients - a Pilot Study
|
N/A | |
| Completed |
NCT02236611 -
A 12-week Study to Evaluate the Efficacy and Safety of Umeclidinium 62.5 Microgram (mcg) Compared With Glycopyrronium 44 mcg in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 4 | |
| Completed |
NCT00153075 -
Flow Rate Effect Respimat Inhaler Versus a Metered Dose Inhaler Using Berodual in Patients With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 4 | |
| Completed |
NCT01009463 -
A Study to Evaluate the Efficacy and Safety of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 3 | |
| Completed |
NCT01017952 -
A Study to Evaluate Annual Rate of Exacerbations and Safety of 3 Dosage Strengths of Fluticasone Furoate (FF)/GW642444 Inhalation Powder in Subjects With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 3 | |
| Completed |
NCT04882124 -
Study of Effect of CSJ117 on Symptoms, Pharmacodynamics and Safety in Patients With COPD
|
Phase 2 | |
| Completed |
NCT02853123 -
Effect of Tiotropium + Olodaterol on Breathlessness in COPD Patients
|
Phase 4 | |
| Completed |
NCT02619357 -
Method Validation Study to Explore the Sensitivity of SenseWear Armband Gecko for Measuring Physical Activity in Subjects With Chronic Obstructive Pulmonary Disease (COPD) & Asthma
|
Phase 1 | |
| Recruiting |
NCT05858463 -
High Intensity Interval Training and Muscle Adaptations During PR
|
N/A | |
| Not yet recruiting |
NCT05032898 -
Acute Exacerbation of Chronic Obstructive Pulmonary Disease Inpatient Registry Study Stage II
|